KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).